LEUKOLIFE

Brought together through Heart Failure and an eventual transplant, our team is a unique assembly of an internationally recognized doctor, healthcare leaders, members of the scientific community, marketers and a heart transplant recipient all with a shared passion to improve survival benefit in advanced heart failure patients... Use of the MyLeukoMAP assay to identify the 20% High-risk patients not identified by current diagnostics will allow cardiologists to prescribe therapy that matches individual patient survival probability.
 We believe that the use of our assay to guide therapy will significantly improve the treatment of Heart Failure from the standpoint of the patient, the healthcare provider, and the healthcare system overall.